Trial intelligence / Profile preview

Oral and Neuro-Penetrative Alternative Antibiotics for Patients with Syphilis

2024-514984-24-00Phase 4Completed

Sponsor: Fight AIDS and Infectious Diseases Foundation
Start: Sep 2024
Modality: Small Molecules
Countries: 2

Overview

Phase 4, randomised trial of linezolid in syphilis (2 arms), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoints: Clinical cure, Serological cure and 1 more. Started Sep 2024; status: completed.

Drugs

linezolid

Conditions

syphilis

Beyond the preview

Go deeper on 2024-514984-24-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-514984-24-00.